Yong-ki K. Min
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 51 publications
Modulation of Bone Mineral Density and Its Response to Menopausal Hormone Therapy according to the Apolipoprotein E Genotype in Postmenopausal Korean Women.
Journal: Journal of menopausal medicine
Published: October 14, 2023
Effects of Bazedoxifene/Vitamin D Combination Therapy on Serum Vitamin D Levels and Bone Turnover Markers in Postmenopausal Women with Osteopenia: A Randomized Controlled Trial.
Journal: Journal of bone metabolism
Published: March 22, 2023
Raloxifene/Vitamin D Combination Therapy vs. Raloxifene Monotherapy on Serum 25-Hydroxy-Vitamin D Level among Postmenopausal Women with Osteoporosis or Osteopenia: A Randomized Controlled Trial.
Journal: Journal of bone metabolism
Published: April 28, 2022
Bone Mineral Density Screening Interval and Transition to Osteoporosis in Asian Women.
Journal: Endocrinology and metabolism (Seoul, Korea)
Published: February 04, 2022
Efficacy of bisphosphonate therapy on postmenopausal osteoporotic women with and without diabetes: a prospective trial.
Journal: BMC endocrine disorders
Published: November 23, 2021
Bone-density testing interval and transition to osteoporosis in differentiated thyroid carcinoma patients on TSH suppression therapy.
Journal: Clinical endocrinology
Published: October 21, 2021
Effects of Combination Oral Contraceptives on Bone Mineral Density and Metabolism in Perimenopausal Korean Women.
Journal: Journal of menopausal medicine
Published: September 28, 2021
Preventing Rebound-Associated Fractures after Discontinuation of Denosumab Therapy: A Position Statement from the Health Insurance Committee of the Korean Endocrine Society.
Journal: Endocrinology and metabolism (Seoul, Korea)
Published: July 19, 2021
Comparison of Four Ultrasonography-Based Risk Stratification Systems in Thyroid Nodules with Nondiagnostic/Unsatisfactory Cytology: A Real-World Study.
Journal: Cancers
Published: March 11, 2021
Romosozumab in Postmenopausal Korean Women with Osteoporosis: A Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study.
Journal: Endocrinology and metabolism (Seoul, Korea)
Published: September 23, 2020
High circulating follistatin-like protein 1 as a biomarker of a metabolically unhealthy state.
Journal: Endocrine journal
Published: February 13, 2019
Assessment of patient-reported outcomes (PROs): treatment satisfaction, medication adherence, and quality of life (QoL) and the associated factors in postmenopausal osteoporosis (PMO) patients in Korea.
Journal: Journal of bone and mineral metabolism
Published: October 30, 2017
Last Updated: 09/26/2026